<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03509467</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-17984</org_study_id>
    <nct_id>NCT03509467</nct_id>
  </id_info>
  <brief_title>Using MC1R Genotype to Impact Melanoma Risk Behavior</brief_title>
  <official_title>Using MC1R Genotype to Impact Melanoma Risk Behavior</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Ponce Health Sciences University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Cancer Society, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine how different messages about risk of melanoma can
      impact the way people protect themselves against developing these diseases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 3, 2015</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sun and Protection Behaviors - Impact of Risk and Prevention Education - Non-Hispanic White Population</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Rate of self-reported, post education changes per study arm: 1.) decrease in sun exposure, 2.) increase in sun protection.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin Awareness and Examination - Impact of Risk and Prevention Education - Hispanic Population</measure>
    <time_frame>Up to 9 months</time_frame>
    <description>Rate of self-reported, post education changes per study arm: Increase in skin examinations.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin Awareness and Examination - Impact of Risk and Prevention Education - Non-Hispanic White Population</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Rate of self-reported, post education changes per study arm: Increase in skin examinations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of Receipt of MC1R Genotype on Sun Protection Behaviors in Children - Non-Hispanic White Population</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Impact of receipt of MC1R genotype on sun protection behaviors in children of study participants. Self-reported post education decreased number of sunburns.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of Receipt of MC1R Genotype on Sun Protection Behaviors in Children - Hispanic Population</measure>
    <time_frame>Up to 9 months</time_frame>
    <description>Impact of receipt of MC1R genotype on sun protection behaviors in children of study participants. Self-reported post education decreased number of sunburns.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">1312</enrollment>
  <condition>Melanoma (Skin)</condition>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Squamous Cell Cancer</condition>
  <condition>Skin Cancer</condition>
  <condition>Basal Cell Carcinoma</condition>
  <condition>Basal Cell Cancer</condition>
  <arm_group>
    <arm_group_label>Intervention Group A - Now Open</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Group A: Non-Hispanic White Population
Post determination of MC1R Genotypes, participants randomized to the intervention group, will receive personalized information about ways that they can protect themselves and their child from developing melanoma.
By the end of the study, all participants will have had the opportunity to receive information about their inherited risk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Group B - Will Open Soon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Group B: Hispanic Population
Post determination of MC1R Genotypes, participants randomized to the intervention group, will receive personalized information about ways that they can protect themselves and their child from developing melanoma.
By the end of the study, all participants will have had the opportunity to receive information about their inherited risk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group A - Now Open</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control Group A: Non-Hispanic White Population
Post determination of MC1R Genotypes, participants randomized to the control group, you will receive standard information about ways that they can protect themselves and their child from developing melanoma.
By the end of the study, all participants will have had the opportunity to receive information about their inherited risk. Participants randomized into the control group, by the end of the study will also have had the opportunity to receive personalized information about ways they can protect themselves and their child from developing melanoma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group B - Will Open Soon</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control Group B: Hispanic Population
Post determination of MC1R Genotypes, participants randomized to the control group, you will receive standard information about ways that they can protect themselves and their child from developing melanoma.
By the end of the study, all participants will have had the opportunity to receive information about their inherited risk. Participants randomized into the control group, by the end of the study will also have had the opportunity to receive personalized information about ways they can protect themselves and their child from developing melanoma.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Personalized Information</intervention_name>
    <description>Personalized information about ways that participants can protect themselves and their child from developing melanoma.</description>
    <arm_group_label>Intervention Group A - Now Open</arm_group_label>
    <arm_group_label>Intervention Group B - Will Open Soon</arm_group_label>
    <other_name>educational materials</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Information</intervention_name>
    <description>Standard information about ways that participants can protect themselves and their child from developing melanoma.</description>
    <arm_group_label>Control Group A - Now Open</arm_group_label>
    <arm_group_label>Control Group B - Will Open Soon</arm_group_label>
    <other_name>educational materials</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>DNA Extraction Determination of MC1R Genotypes</intervention_name>
    <description>After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.</description>
    <arm_group_label>Intervention Group A - Now Open</arm_group_label>
    <arm_group_label>Intervention Group B - Will Open Soon</arm_group_label>
    <arm_group_label>Control Group A - Now Open</arm_group_label>
    <arm_group_label>Control Group B - Will Open Soon</arm_group_label>
    <other_name>risk factor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        CRITERIA FOR: NON-HISPANIC WHITE POPULATION - NOW RECRUITING

          -  Investigators will recruit participants from the Family Medicine and General Internal
             Medicine clinics of the Morsani Center at the University of South Florida.

          -  White, non-Hispanic patients who self-report a low phenotypic risk profile for
             development of melanoma and are able to read and speak English fluently.

          -  18 years of age or older

          -  Capable of giving informed consent

          -  Potential participants will be screened for eligibility based on responses to
             questions about skin phenotypes, early detection behaviors and past history of
             melanoma.

          -  After signing informed consent, a biologic sample (saliva) will be collected for the
             purpose of DNA extraction determination of MC1R genotypes. All participants who carry
             high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R
             variants will be randomized to the control or intervention arm.

        CRITERIA FOR: HISPANIC POPULATION - WILL BEGIN RECRUITING SOON

          -  Investigators will recruit participants living in Tampa Bay and Puerto Rico as part of
             the U54 Ponce Health Sciences University-Moffitt Cancer Center (PHSU-MCC) Partnership.
             In Tampa Bay, participants will be recruited from the Family Medicine and General
             Internal Medicine clinics of the Morsani Center at the University of South Florida,
             and from the Suncoast Community Health Centers.

          -  Patients who self-report as Hispanics and are able to read and speak either Spanish or
             English fluently.

          -  18 years of age or older

          -  Capable of giving informed consent

          -  Potential participants will be screened for eligibility based on responses to early
             detection behaviors and past history of melanoma.

          -  After signing informed consent, a biologic sample (saliva) will be collected for the
             purpose of DNA extraction determination of MC1R genotypes. All participants who carry
             high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R
             variants will be randomized to the control or intervention arm.

        Exclusion Criteria:

        CRITERIA FOR: NON-HISPANIC WHITE POPULATION - NOW RECRUITING

          -  Have had a skin examination within the past year.

          -  Do not meet race/ethnicity criteria for their group

          -  White, non-Hispanic group - participants reporting sun-sensitive phenotypes

          -  A personal history of melanoma

        CRITERIA FOR: HISPANIC POPULATION - WILL BEGIN RECRUITING SOON

          -  Have had a skin examination within the past year.

          -  Do not meet ethnicity criteria for their group

          -  White, non-Hispanic group - participants reporting sun-sensitive phenotypes

          -  Participants with a personal history of melanoma and/or more personal history of more
             than on squamous cell cancer (SCC) and/or Basal Cell Cancer (BCC)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Kanetsky, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>H. Lee Moffitt Cancer Center and Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H. Lee Moffitt Cancer Center and Research Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jocelyn DelRio</last_name>
      <phone>813-745-2853</phone>
      <email>jocelyn.delrio@moffitt.org</email>
    </contact>
    <contact_backup>
      <last_name>Peter Kanetsky</last_name>
      <phone>813-745-2299</phone>
      <email>peter.kanetsky@moffitt.org</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Kanetsky, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.moffitt.org/research--clinical-trials/clinical-trials</url>
    <description>Moffitt Cancer Center Clinical Trials website</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>April 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2018</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>skin cancer prevention</keyword>
  <keyword>educational materials</keyword>
  <keyword>skin cancer risk</keyword>
  <keyword>questionnaire</keyword>
  <keyword>MC1R genotype</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Melanoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
    <mesh_term>Skin Neoplasms</mesh_term>
    <mesh_term>Neoplasms, Squamous Cell</mesh_term>
    <mesh_term>Neoplasms, Basal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

